
Sign up to save your podcasts
Or


At the beginning of the pandemic, Daniel Batlle, MD, professor of medicine in the Division of Nephrology-Hypertension at Northwestern, proposed a hypothesis that soluble ACE2 could treat the SARS-CoV-2 virus and lead to full recovery and survival. Now, he has exciting preliminary results to share.
By Northwestern University Feinberg School of Medicine4.9
2424 ratings
At the beginning of the pandemic, Daniel Batlle, MD, professor of medicine in the Division of Nephrology-Hypertension at Northwestern, proposed a hypothesis that soluble ACE2 could treat the SARS-CoV-2 virus and lead to full recovery and survival. Now, he has exciting preliminary results to share.

91,051 Listeners

21,944 Listeners

43,592 Listeners

91 Listeners

6,469 Listeners

112,275 Listeners

5 Listeners

56,589 Listeners

0 Listeners

10,276 Listeners

33 Listeners

3,037 Listeners

8,213 Listeners

29,305 Listeners

1,587 Listeners

4,300 Listeners

7 Listeners

631 Listeners

12,388 Listeners